PRJZX | RNPHX | PRJZX / RNPHX | |
Total Expense Ratio | 0.92 | 0.56 | 164% |
Annual Report Gross Expense Ratio | 0.92 | 0.56 | 164% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 3.902 | 13.053 | 30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.54B | 156B | 4% |
Annual Yield % from dividends | 0.00 | 0.67 | - |
Returns for 1 year | -1.35 | 11.41 | -12% |
Returns for 3 years | 66.02 | 46.75 | 141% |
Returns for 5 years | 34.93 | 46.57 | 75% |
Returns for 10 years | 200.76 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MUOAX | 31.36 | 0.31 | +1.00% |
Morgan Stanley Instl US Core A | |||
VIEIX | 149.82 | 1.38 | +0.93% |
Vanguard Extended Market Index Instl | |||
GSESX | 65.01 | 0.55 | +0.85% |
Goldman Sachs US Equity Insights Svc | |||
LMVFX | 122.91 | 0.49 | +0.40% |
ClearBridge Value FI | |||
HLHIX | 27.61 | 0.07 | +0.25% |
Virtus KAR Health Sciences Inst |